Bodal Chemicals: Special Window for Dematerialization of Physical Shares Opened
Bodal Chemicals opens a special window from Feb 5, 2026, to Feb 4, 2027, for dematerialization of physical shares. This is for shareholders whose requests lodged before April 1, 2019, were rejected. Shares will be issued in demat form. Newspaper clippings published on April 14, 2026.
This is a routine regulatory compliance announcement related to a process for a specific set of shareholders and does not directly impact the company's operations or financial performance.
The announcement is a procedural update regarding a SEBI directive for dematerialization of physical shares, with no immediate financial impact or significant news for investors.
Bodal Chemicals Limited has announced the opening of a special window for the transfer and dematerialization of physical shares. This initiative, in line with a SEBI circular dated January 30, 2026, will be active from February 5, 2026, to February 4, 2027. The window is specifically for shareholders whose transfer requests were lodged before April 1, 2019, but were rejected or returned due to documentation or procedural deficiencies. Upon successful processing during this period, shares will be issued exclusively in dematerialized (demat) form. Shareholders are encouraged to submit the necessary documents to the company and its Registrar and Transfer Agent, Cameo Corporate Services Limited, to avail this opportunity.
The company also published newspaper clippings of this advertisement in The Indian Express (English) and The Financial Express (Gujarati) on April 14, 2026. The announcement was made by Ashutosh B Bhatt, Company Secretary and Compliance Officer for Bodal Chemicals Limited.
What to do with a filing like this
Bodal Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under shareholding pattern. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Bodal Chemicals Limited. Read the original for the full detail.